VC  Arboretum Ventures

https://www.arboretumvc.com/





     Office Locations:

Market Place Building
303 Detroit Street, Suite 301
Ann Arbor, MI 48104
Phone: 734-998-3688
Fax: 734-998-3689

 

Stages:

  • Early
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Arboretum Ventures is an early-stage venture capital firm specializing in the healthcare sector. Founded in 2002, and headquartered in Ann Arbor, MI, Arboretum currently manages approximately $170 million in capital. The firm invests throughout the United States, but with a special interest in the Midwest. Arboretum is interested in companies that: address large, growing patient populations, redefine how care is delivered, improve patient outcomes, lower the overall cost of healthcare, and operate in a capital-efficient manner. The firm focuses its investing primarily in the following subsectors: medical devices, diagnostics, technology based healthcare services, and life sciences tools. Arboretum is actively investing from its second fund and is seeking to invest approximately $8 to $12 million over the life of a company, with an initial investment ranging from $3 to $7 million. The firm maintains offices in Ohio and Michigan.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Dan Kidle Managing Partner
    Jan Garfinkle Founder and Managing Partner
    Paul McCreadie Partner and COO
    Tim Petersen Founder and Managing Partner
    Tom Shehab MD Managing Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      10/08/2024


      Orasis Pharmaceuticals


      FL


      $78,000,000


      Series D


      06/27/2024


      RareCyte


      WA


      $20,000,000


      Venture


      02/20/2024


      Reprieve Cardiovascular


      MA


      $42,000,000


      Series A


      01/24/2024


      Motif Neurotech


      TX


      $18,750,000


      Series A


     

    Portfolio companies include:

     

    Recent News: